Normal view MARC view ISBD view

The leaders of quality improvement are the ones who are doing the improvement work. [electronic resource]

By:

Bethune, Rob M

Producer: 20130812Description: 210 p. digitalISSN:

1758-1095

Subject(s):

Online resources:

Available from publisher's website

In: Journal of the Royal Society of Medicine vol. 106

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Letter; Comment

There are no comments on this title.

to post a comment.

Back to results

4841 Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
by Miyazaki, Y
4842 Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis.
by Mori, F
4843 The Computerized Test of Information Processing (CTIP) offers an alternative to the PASAT for assessing cognitive processing speed in individuals with multiple sclerosis.
by Tombaugh, Tom N
4844 Placebo cohorts in phase-3 MS treatment trials - predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data.
by Stellmann, Jan-Patrick
4845 The effect of plasma exchange on serum anti-JC virus antibodies.
by Subramanyam, Meena
4846 Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
by Cortese, I
4847 Corpus callosal diffusivity predicts motor impairment in relapsing-remitting multiple sclerosis: a TBSS and tractography study.
by Kern, Kyle C
4848 Genetic variation in PBMC-produced IFN-γ and TNF-α associations with relapse in multiple sclerosis.
by Zhou, Yuan
4849 Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function.
by Marcos-Ramiro, Beatriz
4850 Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.
by Kalincik, Tomas
4851 Experimental protocol of a randomized controlled clinical trial investigating exercise, subclinical atherosclerosis, and walking mobility in persons with multiple sclerosis.
by Griffith, Garett
4852 Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
by Kappos, Ludwig
4853 Erythrocyte membrane fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.
by Rezapour-Firouzi, Soheila
4854 Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosis.
by Pappalardo, Laura W
4855 Phospholipase D1 expression analysis in relapsing-remitting multiple sclerosis patients.
by Eftekharian, Mohammad Mahdi
4856 Efficacy of immunomodulatory therapy with interferon-β or glatiramer acetate on multiple sclerosis-associated uveitis.
by Velazquez-Villoria, D
4857 Improvement of postural control in individuals with multiple sclerosis after a single-session of ball throwing exercise.
by Aruin, Alexander S
4858 JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients.
by Basnyat, Pabitra
4859 Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL.
by Opfer, Roland
4860 Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.
by Cunill, Vanesa